Delivery Order SPE2DX22D0020-SPE2D826F03FB
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,019.45 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $24,907.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. The contract, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $24,909.96 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work is to be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,484.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 7, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $8,740.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This non-set-aside competitive award was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order represents a routine...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work is being performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $734,016.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract is performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $211,138.11 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,493.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vendor, headquartered in...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F03FBDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $3,045.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. AmerisourceBergen Drug Corp is a critical federal vendor specializing in comprehensive pharmaceutical and medical supply distribution to support military and veteran healthcare systems. Under the broader SPE2DX vehicle, the company supplies an extensive portfolio of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The prime IDC serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this specific delivery order representing a routine transaction within that established framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/24/25 |